National Drug Early Warning System (NDEWS) Weekly Briefing

NDEWS ORIGINAL CONTENT

Substance use in the past 12 months: Tampa, Florida Survey Dates: February 18-20, 2022

The National Drug Early Warning System (NDEWS) Rapid Street Reporting (RSR) team visited Tampa, FL on February 18-20, 2022. Tampa was chosen as a Hotspot location based on recent increases in drug-related 911 emergency medical services dispatches reported by biospatial.io. The RSR team conducted surveys in public spaces, including sidewalks near pedestrian walkways, downtown areas, public parks, shopping mall areas, skate parks, and nightlife areas such as bars and clubs within Tampa.
Read the full report here.

NEW PSYCHOACTIVE SUBSTANCES

NPS Discovery announcement of newly identified novel psychoactive substance in the US: Dipyanone

Earlier this week NPS Discovery announced the identification of dipyanone, a new synthetic opioid beginning to emerge in the US. Read the full report here.

RECENTLY PUBLISHED

Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238

A manuscript recently published in Archives of Toxicology, by investigators affiliated with the Center for Forensic Science Research and Education, including NDEWS Scientific Advisory Group member Dr. Barry Logan, reports on the toxicological profile for antemortem and postmortem cases where novel synthetic opioids of the cinnamylpiperazine class, including 2-methyl AP-237 and AP-238, were detected.The cases were received between February 2020 and April 2021. Read the full manuscript here.

Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances

The International Narcotics Board published their annual report on precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances last week. Read the full report here.

Kratom misuse potential 2021: An updated eight factor analysis

An article published in Frontiers in Pharmacology describes an update on the misuse potential of kratom based on the eight factors of the US Controlled Substances Act. The review summarizes new scientific findings from January 2018 through August 2021. Read the full article here.

IN THE NEWS

Public health alert by the Ontario Provincial Police: Non-fentanyl synthetic opioid found in seized drugs

The Ontario Provincial Police have issued a warning after a non-fentanyl synthetic opioid was identified in a pill seized from a crime scene in the fall of 2021. Results from a Health Canada laboratory analysis show the pills were composed of isotonitazene, benzodiazepine, and caffeine. Read the full story here.

Postdoctoral Fellowships Available Immediately!

The University of Florida Substance Abuse Training Center in Public Health T32 is seeking applicants for two postdoctoral fellowship openings! 

- Fellowships are sponsored by the National Institute on Drug Abuse, and postdocs receive an annual stipend and health benefits for 2 years. 

- An annual allowance is offered to facilitate attendance at conferences.

- Fellows would work on NDEWS, the ABCD study or other NIDA funded studies with internationally known mentors.

- UF resources include: CTSA; McKnight Brain Institute; Center on Addiction Research and Education; Arts in Medicine; Pain Research and Intervention Center of Excellence; UF Health Cancer Center; Emerging Pathogens Institute; Institute on Aging

- The T32 program is directed by Dr. Linda Cottler, and co-directed by Dr. Sara Jo Nixon.

Questions should be directed to Ms. Tamara Millay at tmillay@ufl.edu. Applications are considered on a rolling basis; the program values the diversity of its applicants.

Share your research, news, and events through our submission form

Share your comments on our newsletter through our feedback form

Follow NDEWS on Twitter: @NDEWSnews